UroGen Pharma Ltd. (URGN)
26.31
+1.56
(+6.30%)
USD |
NASDAQ |
Nov 09, 16:00
26.67
+0.36
(+1.37%)
Pre-Market: 09:09
UroGen Pharma Cash and Short Term Investments (Quarterly) : 91.88M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 91.88M |
| June 30, 2026 | 109.30M |
| March 31, 2026 | 141.60M |
| December 31, 2025 | 121.81M |
| September 30, 2025 | 128.38M |
| June 30, 2025 | 158.04M |
| March 31, 2025 | 196.97M |
| December 31, 2024 | 237.76M |
| September 30, 2024 | 250.65M |
| June 30, 2024 | 241.90M |
| March 31, 2024 | 164.87M |
| December 31, 2023 | 137.79M |
| September 30, 2023 | 148.24M |
| June 30, 2023 | 48.12M |
| March 31, 2023 | 65.87M |
| December 31, 2022 | 100.78M |
| September 30, 2022 | 96.72M |
| June 30, 2022 | 112.55M |
| March 31, 2022 | 136.99M |
| Date | Value |
|---|---|
| December 31, 2021 | 90.36M |
| September 30, 2021 | 107.44M |
| June 30, 2021 | 122.26M |
| March 31, 2021 | 77.13M |
| December 31, 2020 | 103.24M |
| September 30, 2020 | 120.85M |
| June 30, 2020 | 126.35M |
| March 31, 2020 | 120.31M |
| December 31, 2019 | 147.60M |
| September 30, 2019 | 158.72M |
| June 30, 2019 | 189.47M |
| March 31, 2019 | 247.10M |
| December 31, 2018 | 101.57M |
| September 30, 2018 | 109.68M |
| June 30, 2018 | 119.31M |
| March 31, 2018 | 127.66M |
| December 31, 2017 | 73.20M |
| September 30, 2017 | 79.37M |
| June 30, 2017 | 77.19M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Xencor, Inc. | 405.08M |
| MeiraGTx Holdings Plc | 143.17M |
| Ironwood Pharmaceuticals, Inc. | 86.38M |
| Viking Therapeutics, Inc. | 959.81M |
| IDEAYA Biosciences, Inc. | 838.54M |